Laboratory TOC Analyzers: Technology Selection and QC Applications

Choose a laboratory TOC analyzer by the carbon fraction, sample matrix and decision you need to support. Establish the required working range, background control, recovery, throughput and records before comparing oxidation or detector options. A low advertised detection limit does not demonstrate that the complete sampling and analytical procedure is suitable for your samples.

Total organic carbon is an aggregate measurement expressed as carbon. It does not identify the contaminating molecule, replace a microbiological test or automatically validate a cleaning procedure. This article provides an original selection matrix and a contrasting sample case. It concerns the laboratory measurement system, rather than the engineering design of a pharmaceutical water loop or a complete residue acceptance strategy.

Start with the application and the real sample

List the intended uses separately: routine pharmaceutical water testing, laboratory investigation, cleaning-rinse or swab extracts, and other process samples. State the decision for each use and identify the controlling specification or approved method. Do not assume that one compendial water application authorises testing every aqueous sample on the same settings.

For each sample family, describe expected organic loading, inorganic carbon, salts, pH, solvent content, particles and available volume. Include unusual but credible samples, not only clean standards. Record which characteristics are known, estimated or still to be studied. The unknowns should become demonstration questions rather than optimistic statements in a purchasing specification.

For cleaning samples, consider the target residues, extraction medium, recovery and interference from the collection materials. TOC can support an appropriate nonspecific analytical strategy, but the carbon result alone cannot identify an individual active substance or assign a health-based residue limit. Inorganic residues and poorly recovered organic material require separate consideration.

Confirm the current compendial and regional context. EDQM’s July 2025 notice identifies a revision of Ph. Eur. 2.2.44 effective from July 2026. That notice is not the complete procedure. The current full USP and Ph. Eur. chapters were not accessed for this article; the laboratory must obtain the applicable texts before fixing criteria or claiming compendial suitability.

Define what the reported carbon result includes

Organic carbon, inorganic carbon and total carbon are different quantities. Inorganic carbon can include dissolved carbon dioxide and carbonate species. Document how the selected configuration separates or accounts for that contribution. A reported result labelled TOC is not adequately defined by the instrument name alone.

Some configurations determine organic carbon from separate total-carbon and inorganic-carbon measurements; others remove inorganic carbon before oxidising the remaining organic fraction. In a difference measurement, assess the uncertainty of both contributing measurements, especially when the organic difference is small. After acidification and purging, assess whether relevant volatile organic material is also lost.

A non-purgeable organic carbon result describes the fraction retained under the specified preparation conditions. Dissolved organic carbon refers to an operationally defined filtered fraction. Filtering a particulate sample to prevent blockage may change the measurand and may introduce contamination or adsorption. It cannot be treated as an invisible equipment-protection step.

Specify units explicitly, such as mass of carbon per volume of sample, and distinguish them from mass of the original residue. Converting carbon to the amount of a particular compound requires a justified composition and suitable recovery; an unknown mixture has no universal conversion factor. The same TOC result can arise from chemically different mixtures.

The useful procurement question is therefore: which sample fraction reaches oxidation, what can be lost or excluded, and how is the reported number calculated? Require that explanation in the demonstration and records. If the decision needs molecular identity, add a suitably specific technique rather than expecting the aggregate TOC signal to provide it.

Compare oxidation and detection as a complete system

The analytical chain must introduce a representative portion, convert relevant organic carbon to a measurable form and quantify the resulting response. Common approaches include high-temperature combustion and wet chemical oxidation promoted by heat or ultraviolet light, including persulfate-based systems. These are families of configurations, not guarantees of equivalent performance.

Combustion-based systems need appropriate sample introduction, oxidation conditions and management of deposits and the gas path. Wet oxidation systems require control of reagent contribution, oxidation capability and matrix effects. Salt loading, difficult-to-oxidise compounds and particles deserve tests on the proposed configuration; a technology label does not establish universal tolerance.

Detection can use nondispersive infrared measurement of carbon dioxide or a conductivity-based approach. Ask how carbon dioxide is transferred or distinguished from other sample contributions, what conditioning is required and which interferences remain. A TOC conductivity detector is not the same measurement task as simply reading the original sample’s water conductivity.

EPA Method 415.3 describes multiple oxidation/detection combinations within its source-water and drinking-water scope. USGS’s 2018 comparison shows why a change of configuration may change recovery for particular sample fractions. These environmental sources support measurement principles; their numerical criteria and sample-preservation rules are not pharmaceutical requirements.

Request evidence for the whole working range, including the lower decision region, representative matrix recovery, repeatability and the effect of preceding high-load samples. Separate a detector specification from performance after collection, preparation and dilution. Neither a low blank nor a successful easy-to-oxidise standard proves recovery of every relevant sample constituent.

Include sampling and contamination in the selection

At low carbon loading, a small contribution from a vial, cap, transfer device or preparation water can become important to the decision. Compare the proposed container and closure as a system, with the intended contact time and handling. “Clean” by visual inspection is not an analytical demonstration of a sufficiently low carbon background.

Establish available sample volume against aspiration, dead volume, repeats required by the method and any retained portion. Examine whether the autosampler mixes the sample where necessary and whether settling changes the portion withdrawn. Record permitted particle handling; do not introduce filtration or decanting merely to obtain a more stable display.

Evaluate storage, transport, closure, temperature and permitted holding time for the actual application. Adsorption, contamination, volatile losses and changes in the sample may matter. Do not copy an environmental method’s acidification or storage period into a pharmaceutical procedure without an applicable basis and verification.

For dilution, consider the dilution water’s carbon contribution and the resulting reporting capability in the original sample. Dilution may reduce matrix loading while making a low residue harder to assess. Record the factor, preparation uncertainty and any blank treatment required by the method; subtracting an arbitrary container blank is not an acceptable universal correction.

Plan a demonstration sequence that includes blanks, representative low samples and a justified high-to-low transition. Define recovery and return-to-background evidence before the trial. Contamination and carryover should influence the choice of sample pathway, grouping and controls; the detailed diagnostic investigation belongs in a separate troubleshooting procedure.

Specify QC evidence without confusing the activities

Calibration establishes the measurement relationship, while verification checks specified requirements. Adjustment changes the system and is not synonymous with either. Qualification addresses the installed equipment for its intended use; validation or verification of the analytical procedure addresses the result obtained for the actual application.

System suitability checks selected aspects of the measurement system and analytical operations for the period of use. Require the applicable reference materials, preparation and evaluation logic to be supported. A successful suitability test does not identify an unknown contaminant or establish recovery from every swab, vial or process matrix.

Request traceable records for reference identity, lot, assigned value or compendial role, preparation, storage and use. Specify original responses, calculations, method settings, exclusions and review. A printed final concentration without the relevant context cannot demonstrate how a questionable result was produced.

Define which evidence will be generated before purchase, during installation/qualification and during routine operation. Use the applicable chapter and procedure to establish acceptance criteria; do not turn a supplier’s standard demonstration into the laboratory’s entire control programme. Detailed calibration and suitability design should remain a separate, application-specific activity.

Evaluate installation, software and the operating life

Confirm bench space, ambient conditions, power, required gases, ventilation, reagent storage and waste handling for the selected configuration. Review heat, pressure, oxidants and electrical hazards through approved installation and safety procedures. The purchase specification should identify who supplies each utility and who verifies its suitability at the instrument.

List consumables and service tasks by function: sample-transfer components, oxidation consumables, reagents, gas-path components and other items actually present. Obtain expected maintenance conditions and access requirements without treating a generic interval as mandatory. Determine which tasks belong to trained operators and which require authorised service.

Evaluate data access, user roles, method versioning, auditability, calculations, review, backup and retrieval. Demonstrate relevant workflows with the proposed software configuration. An optional feature name or a general compliance statement does not establish that the installed system supports the laboratory’s data process.

Include failure recovery and continuity: what happens to a partially completed sequence, consumed sample, changed method or interrupted transfer to the laboratory information system? Preserve original records and the reason for any repeat. Define an alternative testing arrangement or justified downtime response before the instrument becomes a single point of failure.

Compare lifecycle cost using the actual sample mix, preparation effort, blanks, cleaning, standards, consumables, qualification and review workload. A nominal samples-per-hour figure can exclude the activities that determine useful throughput. Record assumptions so later increases in matrix complexity or workload trigger a meaningful reassessment.

Make a documented selection using representative challenges

Separate essential requirements from preferences. An essential requirement needs a source, a measurable demonstration and an acceptance decision; a preference can be weighted transparently. The matrix below is an original GuideGxP reasoning aid. It identifies options to investigate, not pre-approved technologies or universal limits.

Illustrative comparison: low-carbon water and a complex process sample

Consider a laboratory choosing equipment for two hypothetical workloads. The first is low-carbon water with a defined compendial decision. The decisive demonstration includes the complete blank contribution, applicable suitability controls and sample stability. A broad upper range adds little value if the handling background prevents a reliable low-level decision.

The second is a process sample with salts, higher organic loading and possible particles. Here, confirm the measured fraction, matrix compatibility, oxidation recovery, dilution consequences and memory before asking it to share the first workload’s pathway. A successful water demonstration cannot release this application. Conversely, robust measurement of the process sample does not prove the required low-water background.

Possible outcomes include one configuration with demonstrated segregation and controls, different sample pathways, or separate instruments. Decide from recorded evidence, workload and residual risk. These are hypothetical choices without invented results, branded rankings or numerical acceptance claims.

Selection dossier checklist

• Intended decisions, sample families, carbon fractions and applicable source versions.
• Essential performance, preparation, data and installation requirements.
• Representative demonstration plan, original results, deviations and assessment.
• Confirmed limitations, excluded matrices and controls needed before routine use.
• Qualification, method and maintenance responsibilities, training and continuity plan.
• Approval of the selected configuration and triggers for reassessment after change.

Close the decision by linking each essential requirement to evidence or an explicit unresolved action. EU GMP Chapter 6 and Annex 15 support this documented laboratory and equipment lifecycle. Keep any unproven application outside the released scope until the necessary method and equipment evidence is available.

Sources and applicability

Reviewed 29 September 2026. Public USP introduction and EDQM revision notice; relevant EPA/USGS measurement sections; ICH Q14, EU GMP and VIM consulted. Full current compendial procedures were not accessed. Environmental method criteria are not transferred to pharmaceutical samples. Matrix, case and checklist are original GuideGxP guidance.

1. USP. ⟨643⟩ Total Organic Carbon. Public introduction, 2021 citation; full current chapter not accessed.
2. EDQM. EPC adopts three revised texts related to pharmaceutical waters. 18 July 2025; notice of Ph. Eur. 2.2.44 revision effective 1 July 2026, not the full chapter.
3. US EPA. Method 415.3, revision 1.2, September 2009. Determination of Total Organic Carbon and Specific UV Absorbance at 254 nm in Source Water and Drinking Water. Sections 1–4; environmental method, not pharmaceutical acceptance criteria.
4. USGS National Water Quality Laboratory. Technical Memorandum 2018.02: Validation of high-temperature catalytic oxidation carbon analyzers for analysis of organic carbon in water samples. 30 April 2018; original environmental water validation study.
5. ICH / FDA. Q14 Analytical Procedure Development. Guidance, March 2024; intended purpose, performance and control strategy.
6. European Commission. EudraLex Volume 4, Chapter 6: Quality Control. Effective 1 October 2014; laboratory documentation, sampling, testing and reference standards.
7. European Commission. EudraLex Volume 4, Annex 15: Qualification and Validation. Effective 1 October 2015; user requirements and equipment lifecycle.
8. JCGM. International Vocabulary of Metrology, 3rd edition. Entry 2.39, calibration; distinction from adjustment and verification.

Related Pharma Lab articles

• Analytical instrument qualification and USP ⟨1058⟩
• Qualification, method validation and system suitability
• Laboratory TOC: Calibration and System Suitability
• TOC Troubleshooting: Blanks, Contamination and Abnormal Results